Site Members can sign up for company wide alerts
Investigation Overview
An investigation on behalf of investors in shares of Fate Therapeutics, Inc. (NASDAQ: FATE) was announced over potential breaches of fiduciary duties by certain officers and directors at Fate Therapeutics, Inc. The investigation by a law firm concerns whether certain Fate Therapeutics officers and directors breached their fiduciary duties and caused damage to the company and its share...
You must register (for free) or login to view the entire investigation.